Products for Research Use Only

DIDS (sodium salt)

CAT: 0804-HY-D0086-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-D0086-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
DIDS sodium salt (MDL101114ZA) is a dual inhibitor of ABCA1 and VDAC1. DIDS also inhibits RAD51, inhibiting RAD51-mediated homologous pairing and strand exchange reactions. DIDS inhibits anion exchange and binding to red blood cell membranes, inhibits the activation of caspase-3 and -9, and can be used in cancer research[1][2][3][4].
CAS Number
67483-13-0
Product Name Alternative
MDL101114ZA
UNSPSC
12171500
Hazard Statement
H315, H317, H319, H330, H334, H335, H351, H412
Target
RAD51; VDAC
Type
Dye Reagents
Related Pathways
Cell Cycle/DNA Damage; Membrane Transporter/Ion Channel
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/DIDS_sodium_salt.html
Purity
99.13
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=S(C1=CC(N=C=S)=CC=C1/C=C/C2=CC=C(N=C=S)C=C2S(=O)(O[Na])=O)(O[Na])=O
Molecular Formula
C16H8N2Na2O6S4
Molecular Weight
498.48
Precautions
H315, H317, H319, H330, H334, H335, H351, H412
References & Citations
[1]Tsou CY, et al. Activation of soluble guanylyl cyclase prevents foam cell formation and atherosclerosis. Acta Physiol (Oxf) . 2014 Apr;210 (4) :799-810.|[2]Chen H, et al. Inhibition of VDAC1 prevents Ca²⁺-mediated oxidative stress and apoptosis induced by 5-aminolevulinic acid mediated sonodynamic therapy in THP-1 macrophages. Apoptosis. 2014 Dec;19 (12) :1712-26.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Dye Reagents
Clinical Information
No Development Reported
Isoform
VDAC1
Citation 01
Adv Sci (Weinh) . 2021 Nov;8 (21) :e2101936.|Autophagy. 2021 Nov;17 (11) :3592-3606.|Biochem Biophys Res Commun. 2021 Jun 30:560:52-58.|bioRxiv. 2023 Jul 3.|bioRxiv. 2024 July 10.|Br J Pharmacol. 2025 Aug;182 (16) :3923-3951.|Cancer Sci. 2020 Nov;111 (11) :4288-4302.|Cell Death Dis. 2024 Nov 9;15 (11) :811.|CNS Neurosci Ther. 2025 Apr;31 (4) :e70410.|FEBS Open Bio. 2022 Feb;12 (2) :516-522.|Front Pharmacol. 2023 Jun 26:14:1191692. |J Cell Mol Med. 2021 Jun;25 (11) :5238-5249.|Life Sci. 2020 Oct 15;259:118390.|Phytomedicine. 2024 May 28:130:155785.|Proc Natl Acad Sci U S A. 2025 Oct 7;122 (40) :e2502841122.|Sci Total Environ. 2024 Jun 30:946:174246.|SSRN. 2023 Nov 14.|Virulence. 2025 Dec;16 (1) :2490208.|Cell Death Discov. 2023 Jul 8;9 (1) :234.

Chemical Information

Disodium 4,4'-diisothiocyanato-2,2'-stilbenedisulfonate, (E)-

See other relationships...

CAS Number67483-13-0
PubChem CID5702690
IUPAC Namedisodium;5-isothiocyanato-2-[(E)-2-(4-isothiocyanato-2-sulfonatophenyl)ethenyl]benzenesulfonate
Molecular FormulaC16H8N2Na2O6S4
Molecular Weight498.5
Topological Polar Surface Area220
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count10
Rotatable Bond Count4
Heavy Atom Count30
Formal Charge0
Complexity792
SMILES
C1=CC(=C(C=C1N=C=S)S(=O)(=O)[O-])/C=C/C2=C(C=C(C=C2)N=C=S)S(=O)(=O)[O-].[Na+].[Na+]
InChI
InChI=1S/C16H10N2O6S4.2Na/c19-27(20,21)15-7-13(17-9-25)5-3-11(15)1-2-12-4-6-14(18-10-26)8-16(12)28(22,23)24;;/h1-8H,(H,19,20,21)(H,22,23,24);;/q;2*+1/p-2/b2-1+;;
InChIKey
GEPAYBXVXXBSKP-SEPHDYHBSA-L
Chemical Structure
2D Structure
2D structure of Disodium 4,4'-diisothiocyanato-2,2'-stilbenedisulfonate, (E)-
CAS: 67483-13-0
CID: 5702690
Formula: C16H8N2Na2O6S4
MW: 498.5
Interactive 3D Structure
Loading 3D structure...
Computed Properties
PropertyValue
Molecular Weight498.5
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count10
Rotatable Bond Count4
Exact Mass497.90605924
Monoisotopic Mass497.90605924
Topological Polar Surface Area220 Ų
Heavy Atom Count30
Formal Charge0
Complexity792
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count3
Compound Is CanonicalizedYes